Clinical Trial Update: The SAPIEN 3 Ultra System in Intermediate Risk Patients With Symptomatic, Severe Aortic Stenosis [NA]

View source ↗

Summary

A clinical trial evaluating the SAPIEN 3 Ultra System in intermediate-risk patients with symptomatic, severe aortic stenosis has completed and results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• SAPIEN 3 Ultra System

Snippet

Sponsor: Edwards Lifesciences | Conditions: Aortic Valve Stenosis | NA | Status: COMPLETED | Results posted: 2021-01-19